glycoproteins | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

151 results for “glycoproteins”

Trials

View all 109 →

Platelet Glycoproteins in Inherited Thrombocytopathy: Association With Aggregation Studies and Bleeding Severity

50 participants · First posted Aug 27, 2018

Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins

8 participants · First posted Oct 14, 2015

A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus

54 participants · First posted Aug 31, 2001

Drugs

View all 23 →

Herpes simplex glycoprotein vaccine (Chiron)

Isatuximab(Sarclisa)

Conditions: Multiple Myeloma (MM), Refractory Multiple Myeloma +1 more

Algal Glycoprotein Capsule

News

View all 19 →

FDA Approves Moderna's mRNA Influenza Vaccine

Experimental mRNA Vaccine Shows Promise Against Three Ebola Virus Strains in Preclinical Studies

Lenvatinib-Pembrolizumab Combination Shows Promise as First-Line Treatment for Advanced Renal Cell Carcinoma

Page 1 of 16